Advertisement
Genelux Says FDA Grants Fast Track Designation For Olvi-Vec To Treat Ovarian Cancer
(RTTNews) - Immuno-oncology company Genelux Corp. (GNLX) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development program of Olvi-Vec (olvimulogene nanivacirepvec) for the treatment of patients with platinum resistant/refractory ovarian cancer.
The company said the Fast Track designation granted for Olvi-Vec underscores its potential to address unmet medical needs in ovarian cancer.
Genelux is currently conducting OnPrime/GOG-3076, a Phase 3 multi-center, randomized, open-label registrational trial evaluating the efficacy and safety of Olvi-Vec in combination with platinum-based chemotherapy in patients with platinum-resistant/refractory ovarian cancer.
read more
Genelux Appoints Lourie Zak As New CFO
Immuno-oncology company Genelux Corp. (GNLX) announced Monday that Lourie Zak will join the company as Chief Financial Officer, effective August 28, 2023.
RTTNews
|
709 dagar sedan
Bay Street Looks Set To Extend Upmove
Canadian shares look headed for a positive start on Wednesday, riding on some impressive corporate earnings updates, and higher oil prices. The focus will also be on the developments on the trade front.
RTTNews
|
32 minuter sedan
Eurozone Retail Sales Recover In June
Euro area retail sales rebounded in June suggesting that household spending likely supported economic growth in the second quarter, official data revealed on Wednesday. Retail sales grew 0.3 percent on a monthly basis in June, offsetting May's 0.3 percent decline, Eurostat said. However, this was marginally weaker than economists' forecast for a 0.4 percent increase.
RTTNews
|
41 minuter sedan
Euro Rises As European Shares Traded Higher
The euro strengthened against other major currencies in the European session on Wednesday, as European shares traded higher despite weak factory orders data from Germany and fresh tariff threats from U.S. President Donald Trump on pharma and chips. Some upbeat earnings announcements and expectations of a Fed interest rate cut next month appear to be aiding sentiment.
RTTNews
|
1h 14minuter sedan
Disney Lifts FY25 EPS View After Q3 Profit Beats Market; ESPN In Deal With WWE, NFL
Media and entertainment major Walt Disney Co. (DIS) on Wednesday raised fiscal 2025 outlook for earnings.above the Street after reporting significantly higher profit in its third quarter, above market estimates. Meanwhile, revenues missed the market view, despite reporting a growth. Separately, Disney announced that its unit ESPN has signed a landmark rights agreement with WWE.
RTTNews
|
1h 31minuter sedan
Dynatrace Boosts FY26 Outlook - Update
While reporting financial results for the first quarter on Wednesday, software intelligence provider Dynatrace, Inc. (DT) provided its adjusted earnings and revenue guidance for the second quarter and raised its outlook for the full-year 2026.
RTTNews
|
1h 37minuter sedan
FTSE 100 Modestly Higher; Hiscox Soars 9%
U.K. stocks are turning in a mixed performance on Wednesday with investors digesting corporate earnings announcements, and continuing to assess the economic impact of the Trump administration's tariffs that are set to become effective this week.
RTTNews
|
2h 5minuter sedan
CAC 40 Up In Positive Territory In Cautious Trade
The French market is modestly higher on Wednesday with corporate earnings announcements providing some direction. Despite data showing a sharp drop in French construction sector activity, and fresh concerns about tariffs following U.S. President Donald Trump's fresh tariff threat, the mood is a bit positive amid hopes the Fed will cut interest rate next month.
RTTNews
|
2h 36minuter sedan
